Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Updates primary CVD prevention recommendations for clinicians; extends 2013 guidance with new risk and therapy thresholds.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
Arnett et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: